• Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use
Saturday, May 10, 2025
28 °c
Agartala
enewstime
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    KIYG 2025: Bihar teams claim rugby 7s gold in contrasting styles; Maharashtra leads medal table

    KIYG 2025: Bihar teams claim rugby 7s gold in contrasting styles; Maharashtra leads medal table

    La Liga 2024-25: Girona coach Michel taken to hospital ahead of key game

    La Liga 2024-25: Girona coach Michel taken to hospital ahead of key game

    Neeraj Chopra Classic 2025 postponed in light of India-Pakistan tension

    Neeraj Chopra Classic 2025 postponed in light of India-Pakistan tension

    Premier League: Erling Haaland 'ready' for Man City return ahead of Southampton trip

    Premier League: Erling Haaland 'ready' for Man City return ahead of Southampton trip

    We salute our armed forces for shielding our nation from terrorism, says Jay Shah

    We salute our armed forces for shielding our nation from terrorism, says Jay Shah

    Xabi Alonso announces Bayer Leverkusen departure

    Xabi Alonso announces Bayer Leverkusen departure

    Alexis Mac Allister wins PL Player of the Month, Wolves' Vitor Pereira bags Manager's award

    Alexis Mac Allister wins PL Player of the Month, Wolves' Vitor Pereira bags Manager's award

    Ricky Kharkongor’s strike takes Meghalaya into Swami Vivekananda Men’s U20 NFC semis

    Ricky Kharkongor’s strike takes Meghalaya into Swami Vivekananda Men’s U20 NFC semis

    Golf: Indian-American Bhatia tied third after 63 in first round of Truist Championship

    Golf: Indian-American Bhatia tied third after 63 in first round of Truist Championship

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    KIYG 2025: Bihar teams claim rugby 7s gold in contrasting styles; Maharashtra leads medal table

    KIYG 2025: Bihar teams claim rugby 7s gold in contrasting styles; Maharashtra leads medal table

    La Liga 2024-25: Girona coach Michel taken to hospital ahead of key game

    La Liga 2024-25: Girona coach Michel taken to hospital ahead of key game

    Neeraj Chopra Classic 2025 postponed in light of India-Pakistan tension

    Neeraj Chopra Classic 2025 postponed in light of India-Pakistan tension

    Premier League: Erling Haaland 'ready' for Man City return ahead of Southampton trip

    Premier League: Erling Haaland 'ready' for Man City return ahead of Southampton trip

    We salute our armed forces for shielding our nation from terrorism, says Jay Shah

    We salute our armed forces for shielding our nation from terrorism, says Jay Shah

    Xabi Alonso announces Bayer Leverkusen departure

    Xabi Alonso announces Bayer Leverkusen departure

    Alexis Mac Allister wins PL Player of the Month, Wolves' Vitor Pereira bags Manager's award

    Alexis Mac Allister wins PL Player of the Month, Wolves' Vitor Pereira bags Manager's award

    Ricky Kharkongor’s strike takes Meghalaya into Swami Vivekananda Men’s U20 NFC semis

    Ricky Kharkongor’s strike takes Meghalaya into Swami Vivekananda Men’s U20 NFC semis

    Golf: Indian-American Bhatia tied third after 63 in first round of Truist Championship

    Golf: Indian-American Bhatia tied third after 63 in first round of Truist Championship

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
enewstime
  • Home
  • News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders
Home Health

This drug may result in weight loss for 3 years in adults without diabetes

IANS by IANS
April 13, 2025
in Health
This drug may result in weight loss for 3 years in adults without diabetes
34
VIEWS
Share on FacebookShare on Twitter

New Delhi, April 13 (IANS) Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss for at least 3 years in adults with overweight or obesity who do not have diabetes, according to new research.

ADVERTISEMENT

The findings also indicate that females and those without obesity-related complications may be more responsive to tirzepatide treatment, said researchers at the European Congress on Obesity (ECO) in Malaga, Spain.

The study, led by Dr Luca Busetto from the University of Padova in Italy and colleagues from Eli Lilly and Company that manufacture tirzepatide, is a continuation of the SURMOUNT-1 phase 3 trial of tirzepatide, a medication approved in the EU and USA for obesity and type 2 diabetes treatment.

The trial uncovered no new safety issues; the most common side effects were nausea, diarrhoea and constipation.

“Our long-term analysis of tirzepatide establishes that clinically relevant weight loss can be sustained for up to 3 years in a diverse population of adults with overweight or obesity but not diabetes, regardless of age, BMI, and duration of obesity at the outset of the study”, said Busetto.

ADVERTISEMENT

But not everyone responds to medication to the same degree and we identified a greater chance of successful weight loss in a group with a higher proportion of females and those with no medical conditions linked to obesity, Busetto added.

Tirzepatide works by mimicking the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) hormones that are naturally secreted by the gut after a meal, which stimulates insulin secretion.

It also reduces appetite by slowing down the time it takes the stomach to empty and interacting with areas in the brain harbouring GLP-1 receptors to signal fullness or satiety.

Tirzepatide was approved in November 2023 by the US Food and Drug Administration (FDA) (Zepbound) and in the EU in June 2024 (Mounjaro) for weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol).

The findings could provide deeper insights into the efficacy of tirzepatide across different demographics and medical histories, potentially allowing for more individualised treatment plans and goals, said the team.

—IANS

na/

*Except for the headings & sub-headings, this story has not been edited by The enewstime.in and has been published from IANS feed.

Related Posts

Fatty liver in pregnancy may increase risk of preterm birth
Health

Fatty liver in pregnancy may increase risk of preterm birth

May 9, 2025
SC fixes May 15 for hearing on pleas challenging lack of transparency in NEET-PG exam
Health

SC fixes May 15 for hearing on pleas challenging lack of transparency in NEET-PG exam

May 9, 2025
Mumbai’s Tata Memorial Hospital receives hoax bomb threat via email
Health

Mumbai’s Tata Memorial Hospital receives hoax bomb threat via email

May 9, 2025
PMSBY’s cumulative enrolments surged by 443 pc since 2016: Centre
Health

PMSBY’s cumulative enrolments surged by 443 pc since 2016: Centre

May 9, 2025
AI-led innovation driving growth in India’s radiology sector: Report
Health

AI-led innovation driving growth in India’s radiology sector: Report

May 9, 2025
US sees increase in cancer incidence rates among adults under 50: Study
Health

US sees increase in cancer incidence rates among adults under 50: Study

May 9, 2025
ADVERTISEMENT
ADVERTISEMENT
D-2050 D-2050 D-2050
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

About us

Enewstime.in is run by an individual – a Journalist by profession of Tripura with the active help of several journos including senior journalists of the State. On top of that, Enewstime.in being a subscriber of IANS news agency, we have plenty of multi-choice topics to offer to our esteemed readers. Enewstime.in is a venture reach global audience from a tiny State Tripura.

Latest News

Justin Bieber drops cryptic posts about honesty and love

India opposes IMF lifeline for Pakistan due to terror financing risk

Focus on boosting agricultural sector in Meghalaya: CM Conrad Sangma

Trump wants India-Pak tensions to de-escalate, says White House

KIYG 2025: Bihar teams claim rugby 7s gold in contrasting styles; Maharashtra leads medal table

G V Prakash, Kayadu Lohar's film titled 'Immortal'

Contact us

ssss

  • Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use

© 2025 Designed & Developed with ❤️ by Provibe Media LLP

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders

© 2025 Designed & Developed with ❤️ by Provibe Media LLP